Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55204-14-3

Post Buying Request

55204-14-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55204-14-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 55204-14-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,2,0 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 55204-14:
(7*5)+(6*5)+(5*2)+(4*0)+(3*4)+(2*1)+(1*4)=93
93 % 10 = 3
So 55204-14-3 is a valid CAS Registry Number.

55204-14-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4-formyl-2-methoxybenzoate

1.2 Other means of identification

Product number -
Other names Methyl 4-formyl-2-methoxy-benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55204-14-3 SDS

55204-14-3Downstream Products

55204-14-3Relevant articles and documents

Compounds with neuroprotective effect, and preparation method and application thereof

-

, (2021/06/13)

The invention relates to compounds with a neuroprotective effect, and a preparation method and application thereof. Specifically, the compounds disclosed by the invention have a structure as shown in a formula I, and the definitions of all groups and subs

Novel compounds that are inhibitors of YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma

-

, (2020/02/01)

These compounds are useful as inhibitors of the YAP/TAZ-TEAD interaction.

HISTONE DEMETHYLASE INHIBITORS

-

Paragraph 0470-0472, (2017/09/08)

This disclosure relates to compounds that inhibit histone demethylase activity. In particular, the disclosure relates to compounds that inhibit histone lysine demethylase KDM5B, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions disclosed herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55204-14-3